Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Survival of motor neuron protein 2 (SMN2) is a gene residing on chromosome 5q13 that encodes the SMN protein—crucial for motor neuron function. It is nearly identical to SMN1 but contains a sequence variant leading to predominant exon 7 skipping and production of a truncated, unstable protein; only about 10–15% of its transcripts give rise to full-length, functional SMN protein[3][1][5]. The SMN protein is essential for assembly of spliceosomal snRNPs and proper pre-mRNA processing within the SMN complex. In spinal muscular atrophy (SMA), loss of SMN1 causes disease, while the SMN2 gene's residual production of functional protein modifies the severity of symptoms. Therapeutic strategies focus on increasing full-length SMN protein from SMN2 by modulating splicing or upregulating gene expression[2][5][1]. The number of SMN2 gene copies directly correlates with severity of SMA: more SMN2 alleles result in milder disease[1][5]. Note: Some aliases cited (GEMIN1, TDRD16B, Gemin-1) refer to separate proteins involved in the SMN complex; they are not correct designations for SMN2[3]. The canonical gene/protein name is "Survival of motor neuron protein 2" (SMN2).
Increasing exon 7 inclusion by splicing modulation (antisense oligonucleotides, small molecules); Upregulation of SMN2 gene expression (epigenetic drugs like HDAC inhibitors); Stabilization of SMN2 mRNA
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival of motor neuron protein 2 (SMN2).